Effect of medication reconciliation on patient reported potential adverse events after hospital discharge

C C M Stuijt1, C L Bekker2, B J F van den Bemt3

  • 1ApoMed Amsterdam, the Netherlands.

Abstract

Insights

Medication reconciliation (MedRec) by a pharmacy team did not reduce the proportion of patients experiencing adverse events (AEs). However, it significantly lowered the median number of potential AEs post-discharge.

Area of Science:

  • Pharmacy practice
  • Patient safety
  • Clinical interventions

Background:

  • Medication reconciliation (MedRec) is known to reduce medication discrepancies.
  • However, its impact on adverse events (AEs) remains less understood.
  • This study investigated the effect of a pharmacy team-led MedRec on patient-reported AEs post-discharge.

Purpose of the Study:

  • To assess the impact of a pharmacy team's medication reconciliation intervention on patient-reported potential adverse events after hospital discharge.
  • To compare the incidence and number of potential AEs between patients receiving usual care and those undergoing enhanced MedRec.

Main Methods:

  • A multicenter prospective intervention study with a before-after design was conducted in two Dutch hospitals.
  • Participants included adult patients discharged with three or more prescription medications.
  • The intervention involved patient education, medication review, and information transfer by a trained pharmacy team.

Main Results:

  • The proportion of patients experiencing AEs was similar between the usual care (88.4%) and intervention (86.7%) groups.
  • The median number of potential AEs per patient was significantly lower in the intervention group (1.1) compared to usual care (2.1).
  • The intervention showed a stronger effect in reducing potential AEs among women.

Conclusions:

  • While medication reconciliation did not decrease the overall proportion of patients with AEs, it significantly reduced the median number of potential AEs.
  • Pharmacy team involvement in MedRec is crucial for improving post-discharge patient safety regarding medication-related adverse events.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
119
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
94
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.1K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
142